The Latest Breaking News from Pfizer

Demand has fallen off in recent months in the country’s three biggest markets, though the reasons vary by region

Officials and global health experts outside China are anxiously watching a COVID-19 surge there, worried a nation of 1.4 billion people is inadequately vaccinated and may not have the healthcare tools to treat a wave of illness expected to kill more than one million people through 2023.

For many parents, respiratory syncytial virus – or RSV – which has been causing record numbers of hospitalizations of children during the fall of 2022, may sound like a relatively new and unheard-of threat. But in fact, RSV is a common respiratory virus that circulates every fall and winter and…

Pfizer Inc. cemented a deal first announced in March to sell its antiviral medication Paxlovid in China through a state-owned company, adding to supply of COVID treatments in the country that’s now facing a massive infection surge.

2 years after Kentucky’s first COVID-19 vaccines, doctors continue to urge people to get vaxxed

With mandatory testing dropped, it can no longer accurately gauge the number of people who have COVID but don’t have symptoms, its National Health Commission said.

Doctors "outraged" after DeSantis pushes investigation and truther panel to refute CDC public health guidance

The Pfizer-BioNTech and Moderna mRNA vaccines have played a large role in preventing deaths and severe infections from COVID-19. But researchers are still in the process of developing alternative approaches to vaccines to improve their effectiveness, including how they’re administered. Immunologist and microbiologist Michael W. Russell of the University at…

Health officials cease recording asymptomatic cases as shortages of medical supplies and testing kits reported in wake of sudden end to strict Covid policy